Due to the higher level of VLCSFAs in cancer serum compared to control (Table 3) we determined the enzymatic index of ELOVL fatty acid elongase 1 (ELOVL1) in serum, estimated by calculating the product/precursor ratio of the fatty acids involved ((C24 + C22 + C20)/C18). The gene discussed is ELOVL5; the disease is cancer.